A healthcare provider may prescribe Bromday (a type of eye drop) to help reduce pain and inflammation caused by cataract surgery. The medication is started the day before the surgery and used for 14 days after the surgery. Although most people do not experience any problems with it, side effects are possible and may include burning, stinging, and eye redness.
Bromday® (bromfenac ophthalmic solution) is a prescription eye drop medication approved to treat pain and inflammation in people who have had cataract surgery. It belongs to a group of medicines known as nonsteroidal anti-inflammatory drugs (commonly referred to as NSAIDs).
Bromday is made by Bausch & Lomb Incorporated under license from Senju Pharmaceuticals Co., Ltd.
As mentioned previously, Bromday belongs to a group of medications called nonsteroidal anti-inflammatory drugs (NSAIDs). As the name states, NSAIDs reduce inflammation. They do this by blocking an enzyme known as cyclooxygenase (COX), which is responsible for the production of substances in the body known as prostaglandins.
Prostaglandins have a variety of functions in the body. One of their roles is to activate an inflammatory response, including inflammation in the eye. They also cause pain. By blocking the production of prostaglandins, Bromday reduces inflammation and pain.
Bromday is given as an eye drop, and works directly in the eye. With normal use, very little, if any, of the drug is absorbed from the eye into the bloodstream.